Photoimmunotherapy and Irradiance Modulation Reduce Chemotherapy Cycles and Toxicity in a Murine Model for Ovarian Carcinomatosis: Perspective and Results
出版年份 2012 全文链接
标题
Photoimmunotherapy and Irradiance Modulation Reduce Chemotherapy Cycles and Toxicity in a Murine Model for Ovarian Carcinomatosis: Perspective and Results
作者
关键词
-
出版物
ISRAEL JOURNAL OF CHEMISTRY
Volume 52, Issue 8-9, Pages 776-787
出版商
Wiley
发表日期
2012-09-14
DOI
10.1002/ijch.201200016
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy
- (2011) Jialiang Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors
- (2011) M. A. Dickson et al. CLINICAL CANCER RESEARCH
- Prognostic significance of the relative dose intensity of chemotherapy in primary treatment of epithelial ovarian cancer
- (2011) Janelle M. Fauci et al. GYNECOLOGIC ONCOLOGY
- Targeted photodynamic therapy – a promising strategy of tumor treatment
- (2011) Andrzej M. Bugaj PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer
- (2010) Jalid Sehouli et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Synergistic Enhancement of Carboplatin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Ovarian Cancer
- (2010) I. Rizvi et al. CANCER RESEARCH
- Farletuzumab in epithelial ovarian carcinoma
- (2010) Whitney A Spannuth et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074)
- (2010) Patricia Pautier et al. GYNECOLOGIC ONCOLOGY
- Optimal Management of Recurrent Ovarian Cancer
- (2010) Maurie Markman INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model
- (2010) Jonathan P. Celli et al. JOURNAL OF BIOMEDICAL OPTICS
- EGFR Signaling and Drug Discovery
- (2010) Georg Lurje et al. ONCOLOGY
- Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
- (2010) Maurie Markman Therapeutics and Clinical Risk Management
- A Current Review of Targeted Therapeutics for Ovarian Cancer
- (2010) Susana M. Campos et al. Journal of Oncology
- Detecting Epidermal Growth Factor Receptor Tumor Activity In Vivo During Cetuximab Therapy of Murine Gliomas
- (2009) Summer L. Gibbs-Strauss et al. ACADEMIC RADIOLOGY
- Novel strategies for reversing platinum resistance
- (2009) Mian M.K. Shahzad et al. DRUG RESISTANCE UPDATES
- EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma
- (2009) Laurie G Hudson et al. Future Oncology
- Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancer
- (2009) Ming-Shien Yen et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence
- (2009) Wim P. Ceelen et al. Nature Reviews Clinical Oncology
- Management of Recurrent Ovarian Carcinoma: Current Status and Future Directions
- (2009) Lainie P. Martin et al. SEMINARS IN ONCOLOGY
- Targeting the EGF Receptor for Ovarian Cancer Therapy
- (2009) Reema Zeineldin et al. Journal of Oncology
- Ovarian Cancer
- (2008) Kathleen R. Cho et al. Annual Review of Pathology-Mechanisms of Disease
- Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer
- (2008) Z Tang et al. BRITISH JOURNAL OF CANCER
- Matrix Metalloproteinase 9 Is a Mediator of Epidermal Growth Factor-Dependent E-Cadherin Loss in Ovarian Carcinoma Cells
- (2008) K. D. Cowden Dahl et al. CANCER RESEARCH
- Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression
- (2008) Laurie G. Hudson et al. CLINICAL & EXPERIMENTAL METASTASIS
- A Phase I Trial of Pemetrexed Plus Gemcitabine Given Biweekly with B-Vitamin Support in Solid Tumor Malignancies or Advanced Epithelial Ovarian Cancer
- (2008) M. L. Hensley et al. CLINICAL CANCER RESEARCH
- Combination of Photodynamic Therapy with Anti-Cancer Agents
- (2008) M.-F. Zuluaga et al. CURRENT MEDICINAL CHEMISTRY
- Pharmaceutical Management of Ovarian Cancer
- (2008) Maurie Markman DRUGS
- Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms
- (2008) Stéphane A Sibani et al. Expert Opinion on Drug Delivery
- Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: A trial of the Chicago, PMH, and California Phase II consortia
- (2008) Halla S. Nimeiri et al. GYNECOLOGIC ONCOLOGY
- A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer
- (2008) Jason Konner et al. GYNECOLOGIC ONCOLOGY
- Combination Chemotherapy and Photodynamic Therapy with Fab′ Fragment Targeted HPMA Copolymer Conjugates in Human Ovarian Carcinoma Cells
- (2008) Jarunee Hongrapipat et al. MOLECULAR PHARMACEUTICS
- Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
- (2007) Agustin A. Garcia et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now